Dr. David Rubin, MD

• Gastroenterology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Chicago Hosps

  Fellowship Hospital

• University Chicago Hosps

  Residency Hospital

• University Of Chicago Pritzker School Of Medicine

  Medical School

• English

• Arabic

• The Drivers of Discretionary Utilization: Clinical History Versus Physician Supply, 2016-10-22

• LONG-TERM TREATMENT OF PATIENTS WITH A HISTORY OF ULCERATIVE COLITIS WHO DEVELOP GASTRITIS AND PAN-ENTERITIS AFTER COLECTOMY, 2013-12-17

• Chronic Pouchitisvs. Recurrent Crohn's Disease: A Diagnostic Challenge, 2013-08-08

• Rifaximin Is Effective for the Treatment ofClostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study, 2011-11-09

• Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis, 2020-08-13

• miR-193a-3p is a key tumor suppressor in ulcerative colitis-associated colon cancer and promotes carcinogenesis through up-regulation of IL17RD, 2017-06-09

• Outcome After Surveillance of Low-grade and Indefinite Dysplasia in Patients with Ulcerative Colitis, 2011-02-14

• Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21stcentury (GIVES-21), 2023-05-25

• Claudin-1 and claudin-2 expression are elevated in inflammatory bowel disease and may contribute to early neoplastic transformation, 2008-08-18

• Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease, 2017-08-24

• Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin, 2015-10-26

• Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease, 2015-12-18

• Patient-SpecificBacteroidesGenome Variants in Pouchitis Vineis et al., 2016-11-15

• Emerging treatment options for extraintestinal manifestations in IBD, 2020-08-26

• Follow-Up of Ulcerative Colitis Patients Who Have Achieved Histological Normalization, 2019-06-20

• Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease, 2016-10-27

• Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases, 2020-03-20

• Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial, 2017-03-04

• Patient-Provider Communications About Pharmacogenomic Results Increase Patient Recall of Medication Changes, 2019-02-04

• Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease, 2018-01-29

• HISTOLOGIC NORMALIZATION OCCURS IN ULCERATIVE COLITIS AND IS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES, 2017-02-24

• Clinical and Translational Considerations for Understanding Depression and Anxiety in Patients with Inflammatory Bowel Disease, 2021-03-05

• Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry, 2020-10-01

• Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis, 2021-01-01

• Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis, 2019-06-11

• Clinical Presentation and Disease Course of Inflammatory Bowel Disease Differs by Race in a Large Tertiary Care Hospital, 2014-04-22

• Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's Disease, 2020-02-26

• Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial, 2017-04-27

• Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease, 2018-01-04

• Effective use of Calcineurin Inhibitors with Vedolizumab in Refractory Inflammatory Bowel Disease, 2018-05-08

• Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics, 2017-05-04

• SECONDARY GASTROINTESTINAL MALIGNANCIES IN CHILDHOOD CANCER SURVIVORS: A COHORT STUDY, 2012-06-05

• Ulcerative Colitis Narrative Global Survey Findings: Communication Gaps and Agreements Between Patients and Physicians, 2020-10-15

• Early transcriptomic changes in the ileal pouch provide insight into the molecular pathogenesis of pouchitis and ulcerative colitis, 2017-10-10

• Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases, 2016-06-09

• Patient perceptions of care as influenced by a large institutional pharmacogenomic implementation program, 2017-04-04

• miR-143 and miR-145 are down-regulated in ulcerative colitis: putative regulators of inflammation and protooncogenes, 2011-05-06

• Activation of the Renin-Angiotensin System Promotes Colitis Development, 2016-06-08

• Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's disease, 2019-02-06

• Risk of Cancer Recurrence Among Individuals Exposed to Anti-Tumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies, 2017-05-21

• Methodology and Initial Results From a Real-World Observational Cohort of Patients With Inflammatory Bowel Disease: TARGET-IBD, 2021-05-13

• Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease, 2021-08-02

• Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis, 2018-04-17

• Metabolic independence drives gut microbial colonization and resilience in health and disease, 2023-04-17

• Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial, 2022-11-14

• Patient Perceptions of Fecal Microbiota Transplantation for Ulcerative Colitis, 2013-08-24

• Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing, 2017-06-15

• Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal Anastomosis, 2020-01-02

• Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial, 2016-02-23

• Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction, 2021-07-13

• Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients with Inflammatory Bowel Disease, 2012-11-28

• Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon, 2017-07-26

• Inflammation is an Independent Risk Factor for Colonic Neoplasia in Patients with Ulcerative Colitis: a Case-Control Study, 2013-07-17

• A comparison of the risk of postoperative recurrence between African-American and Caucasian Crohn's disease patients, 2018-08-20

• Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management, 2021-08-03

• Efficacy and Follow-up of Sub-Total Colectomy With Ileo-Rectal Anastomoses in Patients With Colitis-associated Neoplasia, 2018-05-08

• Histologic Healing is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing, 2019-12-05

• miR-4728-3p functions as a tumor suppressor in ulcerative colitis-associated colorectal neoplasia through regulation of focal adhesion signaling, 2017-06-13